CLXPF News and Press, Canadian Lynx Pete Ltd From 07/02/21

This is Psychedellux – the weekly recap of the business news in the psychedelics industry. Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) released financial and business highlights for its financial year ended March 31, 2021. The company noted that it h...

The company develops medicinal psychedelic compounds and focuses on psilocybin, which can be found in magic mushrooms. I like the strength of the balance sheet as well as the track record of the management team. The future for psychedelic-assisted therapeutic solutions looks brigh...

Gov. Greg Abbott of Texas recently approved a legislation that makes it compulsory for the state to look into the therapeutic potential of psychedelics. This approval was made only a few days after the governor signed a separate bill to expand the state’s medical cannabis program....

A study recently published in the “ Journal of Clinical Psychopharmacology ” has found that some domestic mass shooters in the United States suffer from psychiatric disorders that they haven’t been treated for or received medication for. The report, written by Ira D. Gli...

Cybin (NEO: CYBN) (OTCQB: CLXPF) , a biotechnology company focused on progressing psychedelic therapeutics, today released financial and business highlights for its financial year ended March 31, 2021. “It has been an incredibly busy and successful year for the Cybin team, expanding ...

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) released financial and business highlights for its financial year ended March 31, 2021. The company noted that it had a net loss of  $32.2 million for the year ended March 31, 2021 of which non-cash expenses totaled $13.1 million and ...

NEW YORK, June 28, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from the June 24 th conference are now available for on-demand viewing at LifeSciencesInvestorForum.com. This virtual event showcased live company presentations and inte...

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on psychedelic pharmaceutical therapies, is pleased to announce that Adelia Therapeutics Inc. (“ Adelia ”), a wholly-contro...

Cybin Inc. ( NEO:CYBN ) (OTCQB:CLXPF) (“ Cybin ” or the “ Company ”), a biotechnology company focused on progressing psychedelic therapeutics, today released financial and business highlights for its financial year ended March 31, 2021. Unless...

Cybin (NEO: CYBN) (OTCQB: CLXPF) is a leading biotechnology company focused on progressing psychedelic therapeutics. The company has announced that its Chief Executive Officer Doug Drysdale will participate in a virtual fireside chat at Grizzle Psychedelics Con on June 28, 2021. The firesi...